MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Net Income
-$56,083K
EPS
-$0.76
Unit: Thousand (K) dollars
Income Statement
2026-06-30
2026-03-31
2025-09-30
2025-06-30
Research and development
50,065
36,053
22,010
22,547
General and administrative
8,851
7,392
5,391
5,231
Total operating expenses
58,916
43,445
27,401
27,778
Loss from operations
-58,916
-43,445
-27,401
-27,778
Interest income
3,228
3,102
2,254
1,828
Change in fair value of convertible notes payable
0
-
0
6,184
Other expense
-62
-9
-28
-
Total other income (expense), net
3,166
3,093
2,226
-4,356
Net loss before income tax expense
-55,750
-40,352
-
-
Income tax expense
15
16
-
-
Net loss
-55,765
-40,368
-25,175
-32,134
Currency translation adjustment
-73
2
18
-24
Unrealized holding gain on investments
-
-
35
-
Unrealized loss on investments
-245
-473
-
-
Comprehensive loss
-56,083
-40,839
-25,122
-32,158
Basic EPS
-0.76
-0.57
-0.48
-0.86
Diluted EPS
-0.76
-0.57
-0.48
-0.86
Basic Average Shares
61,050,775
57,777,165
39,584,489
28,431,158
Diluted Average Shares
61,050,775
57,777,165
39,584,489
28,431,158
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Comprehensive loss-$56,083K (-74.40%↓ Y/Y)Net loss-$55,765K (-73.54%↓ Y/Y)Unrealized loss oninvestments-$245K Currency translationadjustment-$73K (-204.17%↓ Y/Y)Interest income$3,228K (76.59%↑ Y/Y)Net loss beforeincome tax expense-$55,750K Income tax expense$15K Total other income(expense), net$3,166K (172.68%↑ Y/Y)Other expense-$62K Loss from operations-$58,916K (-112.10%↓ Y/Y)Total operatingexpenses$58,916K (112.10%↑ Y/Y)Research and development$50,065K (122.05%↑ Y/Y)General andadministrative$8,851K (69.20%↑ Y/Y)

Jade Biosciences, Inc. (JBIO)

Jade Biosciences, Inc. (JBIO)